IL2RG: A Potential Drug Target Or Biomarker (G3561)

Target Name: IL2RG

NCBI ID: G3561

IL2RG

IL2RG: A Potential Drug Target Or Biomarker

IL2RG, or Interleukin-2 receptor subunit gamma, is a protein that is expressed in various tissues throughout the body. It is a key component of the interleukin-2 receptor, which is a protein that is involved in the regulation of immune and inflammatory responses. As a result, IL2RG is a protein that has been identified as a potential drug target or biomarker for a variety of diseases.

The interleukin-2 receptor is a protein that is found on the surface of many different types of cells in the body. It is involved in the regulation of immune responses, including the regulation of T cells, which are a critical part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and they are an important part of the immune system because they help to protect the body against infections and other harmful substances.

IL2RG is a protein that is expressed in various tissues throughout the body, including the lungs, the heart, and the kidneys. It is a key component of the interleukin-2 receptor, which is a protein that is involved in the regulation of immune and inflammatory responses. IL2RG is a protein that has been shown to interact with the interleukin-2 receptor and may help to regulate the activity of this receptor.

One of the potential benefits of targeting IL2RG is that it has been shown to have a variety of different effects on different types of cells. For example, studies have shown that IL2RG can help to stimulate the production of immune cells in the body, such as T cells, and can also help to regulate the activity of these cells. This suggests that targeting IL2RG may be a useful way to treat a variety of different diseases.

In addition to its potential as a drug target, IL2RG is also a potential biomarker for a variety of different diseases. For example, studies have shown that IL2RG levels are often elevated in a variety of different diseases, including cancer and autoimmune disorders. This suggests that measuring IL2RG levels in the body may be a useful way to diagnose and monitor these types of diseases.

Overall, IL2RG is a protein that has been identified as a potential drug target or biomarker for a variety of different diseases. While more research is needed to fully understand the role of IL2RG in the immune system and to develop effective treatments, its potential as a drug target or biomarker is an exciting area of research that is worth further investigation.

Protein Name: Interleukin 2 Receptor Subunit Gamma

Functions: Common subunit for the receptors for a variety of interleukins. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770)

The "IL2RG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL2RG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets